|

Standard vs High Dose of Unfractionated Heparin in the Incidence of Radial Artery Occlusion (DEFINITION) Trial.

RECRUITINGN/ASponsored by Instituto Nacional de Cardiologia Ignacio Chavez
Actively Recruiting
PhaseN/A
SponsorInstituto Nacional de Cardiologia Ignacio Chavez
Started2020-08-01
Est. completion2025-12-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04561648

Summary

Double blind single center clinical trial to compare the incidence of radial artery occlusion (RAO) using standard doses of Unfractionated Heparin (UFH) vs. high doses of UFH.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients over 18 years of age, both genders.
* Successful transradial acess for an elective diagnostic coronary angiography.

Exclusion Criteria:

* Weight \<50 Kg
* Puncture of the ipsilateral radial artery in the last month.
* Still ongoing effect of pre-procedural recently used oral anticoagulants.
* Use of enoxaparin in the past in the last 12 hours prior to the procedure.
* Use of unfractionated heparin in the last 6 hours prior the procedure
* Alterations in coagulation or platelets prone to bleeding or thrombotic complications.
* Anatomical alterations at the radial access site or radial artery.
* Arteriovenous fistula in the ipsilateral arm.
* History of major bleeding associated with the use of UFH.

Conditions2

Heart DiseaseRadial Artery Occlusion

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.